Astrantus’s Nucor NUE Stock Holding History

Astrantus’s Portfolio NUE Stock Details NUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-11,900	Closed	-$1.36M	–	265
2021 Q4	$1.36M	Buy	+11,900	New	+$1.3M	1.02%	11

Other funds holding NUE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Astrantus's NUE Position: Q1 2022 in Review

Astrantus sold out of Nucor (NUE) in Q1 2022, closing a stake of 11,900 shares — an estimated $1.36M sold.

Astrantus first reported a position in NUE in Q4 2021 and held it in 1 quarter. The position peaked at $1.36M in Q4 2021. 1,104 funds tracked by Wall St. Rank hold NUE as of Q1 2022.

Astrantus reported no remaining Nucor position as of Q1 2022 after selling out during the quarter.
Astrantus sold 11,900 Nucor shares in Q1 2022, an estimated $1.36M.
Astrantus first reported a position in Nucor in Q4 2021 and held it in 1 quarter.
Astrantus's Nucor position peaked at $1.36M in Q4 2021.
1,104 funds tracked by Wall St. Rank held Nucor as of Q1 2022.

Based on Astrantus's 13F filing for Q1 2022, filed 11 May 2022.